Pavion Blue Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Buy |
9,787
+788
| +9% | +$19.1K | 0.11% | 93 |
|
|
2025
Q1 | $228K | Hold |
8,999
| – | – | 0.11% | 91 |
|
|
2024
Q4 | $239K | Hold |
8,999
| – | – | 0.11% | 89 |
|
|
2024
Q3 | $260K | Buy |
+8,999
| New | +$260K | 0.12% | 85 |
|
|
2024
Q1 | – | Sell |
-6,987
| Closed | -$201K | – | 102 |
|
|
2023
Q4 | $201K | Sell |
6,987
-2,150
| -24% | -$61.9K | 0.11% | 96 |
|
|
2023
Q3 | $303K | Buy |
9,137
+268
| +3% | +$8.89K | 0.18% | 73 |
|
|
2023
Q2 | $325K | Sell |
8,869
-2,700
| -23% | -$99K | 0.19% | 72 |
|
|
2023
Q1 | $472K | Sell |
11,569
-300
| -3% | -$12.2K | 0.29% | 64 |
|
|
2022
Q4 | $608K | Buy |
11,869
+560
| +5% | +$28.7K | 0.39% | 55 |
|
|
2022
Q3 | $495K | Hold |
11,309
| – | – | 0.35% | 56 |
|
|
2022
Q2 | $593K | Hold |
11,309
| – | – | 0.4% | 54 |
|
|
2022
Q1 | $585K | Buy |
11,309
+588
| +5% | +$30.4K | 0.34% | 54 |
|
|
2021
Q4 | $633K | Sell |
10,721
-200
| -2% | -$11.8K | 0.37% | 54 |
|
|
2021
Q3 | $470K | Hold |
10,921
| – | – | 0.29% | 58 |
|
|
2021
Q2 | $428K | Sell |
10,921
-161
| -1% | -$6.31K | 0.26% | 59 |
|
|
2021
Q1 | $402K | Hold |
11,082
| – | – | 0.26% | 58 |
|
|
2020
Q4 | $408K | Sell |
11,082
-1,599
| -13% | -$58.9K | 0.28% | 59 |
|
|
2020
Q3 | $442K | Buy |
12,681
+993
| +8% | +$34.6K | 0.34% | 57 |
|
|
2020
Q2 | $363K | Buy |
11,688
+1,550
| +15% | +$48.1K | 0.32% | 55 |
|
|
2020
Q1 | $314K | Buy |
+10,138
| New | +$314K | 0.33% | 57 |
|